Abstract

This paper highlights a new, nonspecific medication, which could be used both as a preventive and a curative measure to slow down the progression of Coronavirus disease 2019 (COVID-19) until a more specific treatment is available. The suggested treatment (immunomodulation) consists in the administration of melatonin, a substance shown to inhibit the innate (blind and usually harmful) immune response while facilitating the adaptive one, the only capable of fighting efficiently against the infection. In low oral doses, melatonin can be administered preventively to persons at risk and those already infected but still asymptomatic. High, intravenously administered doses may help critical patients under imminent threat of death. The combined use of both strategies will hopefully unblock the current overcharge of intensive care units by reducing new admissions and favoring healed patient discharge.

How to Cite
TESARIK, Jan. Melatonin to Reduce Death Toll Due to COVID-19: From Innate to Adaptive Immune Response. Global Journal of Medical Research, [S.l.], july 2020. ISSN 2249-4618. Available at: <https://medicalresearchjournal.org/index.php/GJMR/article/view/2168>. Date accessed: 15 aug. 2020.


Organize Conference

We organize seminars /symposium /conferences/workshop/webinar worldwide on innovative topics and fields of Computer Science and research. We also collaborate, partner or sponsor with a view to provide our professional guidance and expertise to conduct in standard way.

Read More

Research Membership

Global Journals Inc., as described in our Corporate Statement, is an educational, research, research publishing, and professional membership organization. Elevation to the ranks of Fellow of the Association of the Research Society in Computer and Member of the Association of the Research Society in Computer is open.

Read More